Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MGEN

Miragen Therapeutics (MGEN) Stock Price, News & Analysis

Miragen Therapeutics logo

About Miragen Therapeutics Stock (NASDAQ:MGEN)

Advanced Chart

Key Stats

Today's Range
$16.78
$17.39
50-Day Range
$14.34
$23.01
52-Week Range
$4.66
$34.05
Volume
477,598 shs
Average Volume
134,027 shs
Market Capitalization
$66.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Miragen Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

MGEN Stock News Headlines

3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
Viridian Therapeutics Inc (VRDN)
See More Headlines

MGEN Stock Analysis - Frequently Asked Questions

Miragen Therapeutics, Inc. (NASDAQ:MGEN) released its earnings results on Tuesday, November, 10th. The medical research company reported ($0.10) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.03. Miragen Therapeutics had a negative net margin of 1,393.50% and a negative trailing twelve-month return on equity of 141.66%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Miragen Therapeutics investors own include Sorrento Therapeutics (SRNE), OPKO Health (OPK), Nokia (NOK), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX) and Pfizer (PFE).

Company Calendar

Last Earnings
11/10/2020
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:MGEN
CIK
1590750
Fax
N/A
Employees
45
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($20.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$41.87 million
Net Margins
-1,393.50%
Pretax Margin
N/A
Return on Equity
-141.66%
Return on Assets
-88.74%

Debt

Debt-to-Equity Ratio
0.20
Current Ratio
4.23
Quick Ratio
4.23

Sales & Book Value

Annual Sales
$4.46 million
Price / Sales
14.93
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.78 per share
Price / Book
2.51

Miscellaneous

Outstanding Shares
3,908,000
Free Float
N/A
Market Cap
$66.59 million
Optionable
Not Optionable
Beta
1.66
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:MGEN) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners